Rhythm Therapeutics

United States Founded: 2014 • Age: 12 yrs
Gene therapy for atrial fibrillation is developed in preclinical stage.
Request Access

About Rhythm Therapeutics

Rhythm Therapeutics is a company based in United States founded in 2014.. Rhythm Therapeutics operates in a competitive market with competitors including Acesion Pharma, Thryv Therapeutics, MITEM Pharma, Inomagen and Blue Ash Therapeutics, among others.

  • Headquarter United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Rhythm Therapeutics

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (21 Nov 2014)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2024 Amount Grant - Rhythm Therapeutics Valuation

investors

Nov, 2014 Amount Debt – Conventional - Rhythm Therapeutics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Rhythm Therapeutics

Rhythm Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Government of Canada. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Online platform providing access to a wide range of government services and information
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Rhythm Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Rhythm Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Rhythm Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Rhythm Therapeutics

Rhythm Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acesion Pharma, Thryv Therapeutics, MITEM Pharma, Inomagen and Blue Ash Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drugs for atrial fibrillation are developed targeting SK ion channels.
domain founded_year HQ Location
Provider of therapy services for rare diseases
domain founded_year HQ Location
Targeted therapies for multiple diseases are developed.
domain founded_year HQ Location
Gene therapy for cardiovascular diseases is developed using electroporation.
domain founded_year HQ Location
Develops innovative drugs targeted at treating cardiovascular disorders.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Rhythm Therapeutics

Frequently Asked Questions about Rhythm Therapeutics

When was Rhythm Therapeutics founded?

Rhythm Therapeutics was founded in 2014.

Where is Rhythm Therapeutics located?

Rhythm Therapeutics is headquartered in United States.

What does Rhythm Therapeutics do?

Rhythm Therapeutics was founded in 2014 in the United States. Gene therapy for atrial fibrillation treatment is being developed by the company within the biotechnology sector. The drug is currently in the preclinical stage, with operations centered on cardiovascular therapeutics. No products have reached clinical trials yet, and activities remain focused on research and development.

Who are the top competitors of Rhythm Therapeutics?

Rhythm Therapeutics's top competitors include Acesion Pharma, Thryv Therapeutics and MITEM Pharma.

Who are Rhythm Therapeutics's investors?

Rhythm Therapeutics has 1 investor. Key investors include Government of Canada.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available